Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−160KRW
−8.43 BKRW
953.95 BKRW
38.65 M
About CHABIOTECH CO.,LTD.
Sector
Industry
CEO
Sang-Hoon Oh
Website
Headquarters
Seoul
Employees (FY)
317
Founded
2002
ISIN
KR7085660009
FIGI
BBG000BRHBL1
Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. It operates through the following business: Cell Therapy Development, Bio, Chaum, and Bio Insurance. The Cell Therapy Development business develops and commercializes cell therapy. The Bio business offers cord blood bank. The Chaum business provides customized medical services for anti-aging. The Bio Insurance business offers storage services of premium and customized blood. The company was founded on November 6, 2002 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 085660 is 17050 KRW — it has decreased by 0.29% in the past 24 hours. Watch CHABIOTECH CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CHABIOTECH CO.,LTD. stocks are traded under the ticker 085660.
085660 stock has risen by 0.71% compared to the previous week, the month change is a 2.16% rise, over the last year CHABIOTECH CO.,LTD. has showed a 17.34% increase.
085660 reached its all-time high on Jan 26, 2018 with the price of 42800 KRW, and its all-time low was 1590 KRW and was reached on Oct 27, 2008. View more price dynamics on 085660 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
085660 stock is 1.88% volatile and has beta coefficient of 1.36. Track CHABIOTECH CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is CHABIOTECH CO.,LTD. there?
Today CHABIOTECH CO.,LTD. has the market capitalization of 962.98 B, it has decreased by 1.39% over the last week.
Yes, you can track CHABIOTECH CO.,LTD. financials in yearly and quarterly reports right on TradingView.
CHABIOTECH CO.,LTD. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
085660 net income for the last quarter is −16.73 B KRW, while the quarter before that showed 5.32 B KRW of net income which accounts for −414.35% change. Track more CHABIOTECH CO.,LTD. financial stats to get the full picture.
No, 085660 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 20, 2024, the company has 317.00 employees. See our rating of the largest employees — is CHABIOTECH CO.,LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHABIOTECH CO.,LTD. EBITDA is 24.59 B KRW, and current EBITDA margin is 2.98%. See more stats in CHABIOTECH CO.,LTD. financial statements.
Like other stocks, 085660 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHABIOTECH CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHABIOTECH CO.,LTD. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHABIOTECH CO.,LTD. stock shows the buy signal. See more of CHABIOTECH CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.